why choose us

First received: January 26, 2023

Clinical Trial: A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atopic Dermatitis

Study Type: OBSERVATIONAL


Official Title: CIBINQO™ Pregnancy Registry: An Observational Study of the Safety of Abrocitinib Exposure in Pregnant Women and Their Offspring

Brief Summary: The purpose of this observational study is to learn about the safety of abrocitinib (CIBINQO) in pregnant women and the offspring.The study is seeking participants who:Are currently or recently pregnantReceive at least one dose of CIBINQO at any time during pregnancy or prior to pregnancy OR have a diagnosis of moderate-to-severe atopic dermatitisAll participants in this study will receive treatment according to routine care, as this is an observational study.The exposed group will consist of pregnant women…

Read more